Cargando…
Maternal serum glycosylated fibronectin as a short-term predictor of preeclampsia: a prospective cohort study
BACKGROUND: Preeclampsia is a major pregnancy complication that results in significant maternal and infant mortality, most of which occurs in low and middle-income countries. The accurate and timely diagnosis of preeclampsia is critical in management of affected pregnancies to reduce maternal and fe...
Autores principales: | Huhn, Evelyn A., Hoffmann, Ina, Martinez De Tejada, Begoña, Lange, Soeren, Sage, Kylie M., Roberts, Charles T., Gravett, Michael G., Nagalla, Srinivasa R., Lapaire, Olav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7041257/ https://www.ncbi.nlm.nih.gov/pubmed/32093623 http://dx.doi.org/10.1186/s12884-020-2809-2 |
Ejemplares similares
-
Diagnostic Accuracy of Different Soluble fms-Like Tyrosine Kinase 1 and Placental Growth Factor Cut-Off Values in the Assessment of Preterm and Term Preeclampsia: A Gestational Age Matched Case-Control Study
por: Huhn, Evelyn A., et al.
Publicado: (2018) -
Glycosylated fibronectin point‐of‐care test for diagnosis of pre‐eclampsia in a low‐resource setting: a prospective Southeast Asian population study
por: Nagalla, SR, et al.
Publicado: (2020) -
Quantitative Proteomic (iTRAQ) Analysis of 1st Trimester Maternal Plasma Samples in Pregnancies at Risk for Preeclampsia
por: Kolla, Varaprasad, et al.
Publicado: (2012) -
Excessive Neutrophil Activity in Gestational Diabetes Mellitus: Could It Contribute to the Development of Preeclampsia?
por: Vokalova, Lenka, et al.
Publicado: (2018) -
Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?
por: Hahn, Sinuhe, et al.
Publicado: (2015)